Natixis Advisors’s Amgen AMGN Stock Holding History

Natixis Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$138M	Buy	392,002 +45,963	+13%	+$16.4M	0.19%	118
2025 Q4	$113M	Buy	346,039 +4,982	+1%	+$1.58M	0.16%	139
2025 Q3	$96.2M	Buy	341,057 +2,403	+0.7%	+$697K	0.14%	164
2025 Q2	$94.6M	Buy	338,654 +14,001	+4%	+$3.97M	0.15%	155
2025 Q1	$101M	Buy	324,653 +43,086	+15%	+$12.7M	0.19%	123
2024 Q4	$73.4M	Sell	281,567 -11,157	-4%	-$3.31M	0.14%	157
2024 Q3	$94.3M	Buy	292,724 +15,092	+5%	+$4.94M	0.18%	124
2024 Q2	$86.7M	Buy	277,632 +30,482	+12%	+$8.95M	0.19%	122
2024 Q1	$70.3M	Sell	247,150 -2,677	-1%	-$783K	0.16%	138
2023 Q4	$72M	Buy	249,827 +17,043	+7%	+$4.64M	0.19%	127
2023 Q3	$62.6M	Buy	232,784 +32,776	+16%	+$8.18M	0.19%	119
2023 Q2	$44.4M	Sell	200,008 -5,358	-3%	-$1.24M	0.14%	167
2023 Q1	$49.6M	Buy	205,366 +6,585	+3%	+$1.62M	0.17%	144
2022 Q4	$52.2M	Buy	198,781 +7,991	+4%	+$2.14M	0.2%	140
2022 Q3	$43M	Sell	190,790 -4,554	-2%	-$1.1M	0.18%	144
2022 Q2	$47.5M	Buy	195,344 +27,447	+16%	+$6.73M	0.21%	123
2022 Q1	$40.6M	Buy	167,897 +18,481	+12%	+$4.25M	0.15%	156
2021 Q4	$33.6M	Buy	149,416 +11,178	+8%	+$2.36M	0.13%	179
2021 Q3	$29.4M	Sell	138,238 -16,866	-11%	-$3.88M	0.12%	178
2021 Q2	$37.8M	Buy	155,104 +1,859	+1%	+$457K	0.18%	144
2021 Q1	$38.1M	Buy	153,245 +9,536	+7%	+$2.28M	0.2%	129
2020 Q4	$33M	Sell	143,709 -28,126	-16%	-$6.48M	0.19%	130
2020 Q3	$43.7M	Sell	171,835 -13,064	-7%	-$3.24M	0.27%	76
2020 Q2	$43.6M	Sell	184,899 -154,954	-46%	-$35.4M	0.29%	70
2020 Q1	$68.9M	Buy	339,853 +8,999	+3%	+$1.97M	0.56%	34
2019 Q4	$79.8M	Buy	330,854 +15,901	+5%	+$3.51M	0.56%	33
2019 Q3	$60.9M	Buy	314,953 +11,156	+4%	+$2.14M	0.48%	43
2019 Q2	$56M	Buy	303,797 +569	+0.2%	+$102K	0.46%	48
2019 Q1	$57.6M	Buy	303,228 +7,705	+3%	+$1.47M	0.5%	42
2018 Q4	$57.5M	Sell	295,523 -397	-0.1%	-$77.5K	0.57%	36
2018 Q3	$61.3M	Sell	295,920 -1,115	-0.4%	-$220K	0.54%	38
2018 Q2	$54.8M	Sell	297,035 -9,977	-3%	-$1.76M	0.52%	35
2018 Q1	$52.3M	Buy	307,012 +15,153	+5%	+$2.78M	0.52%	36
2017 Q4	$50.8M	Buy	291,859 +5,128	+2%	+$908K	0.52%	38
2017 Q3	$53.5M	Sell	286,731 -4,678	-2%	-$829K	0.56%	33
2017 Q2	$50.2M	Buy	291,409 +3,029	+1%	+$493K	0.54%	36
2017 Q1	$47.3M	Buy	288,380 +44,046	+18%	+$7.32M	0.52%	37
2016 Q4	$35.7M	Buy	244,334 +13,348	+6%	+$2.01M	0.43%	47
2016 Q3	$38.5M	Buy	230,986 +27,109	+13%	+$4.58M	0.5%	37
2016 Q2	$31M	Buy	203,877 +26,206	+15%	+$4.07M	0.43%	43
2016 Q1	$26.6M	Buy	177,671 +15,619	+10%	+$2.32M	0.4%	47
2015 Q4	$26.3M	Buy	162,052 +8,374	+5%	+$1.32M	0.43%	40
2015 Q3	$21.3M	Buy	153,678 +5,170	+3%	+$815K	0.37%	49
2015 Q2	$22.8M	Buy	148,508 +16,819	+13%	+$2.69M	0.39%	38
2015 Q1	$21.1M	Buy	131,689 +14,576	+12%	+$2.3M	0.37%	40
2014 Q4	$18.7M	Buy	117,113 +1,945	+2%	+$303K	0.35%	42
2014 Q3	$16.2M	Sell	115,168 -51,646	-31%	-$6.74M	0.32%	50
2014 Q2	$19.7M	Buy	166,814 +1,308	+0.8%	+$151K	0.28%	65
2014 Q1	$20.4M	Buy	165,506 +13,465	+9%	+$1.63M	0.31%	52
2013 Q4	$17.3M	Buy	152,041 +18,530	+14%	+$2.11M	0.28%	74
2013 Q3	$14.9M	Buy	133,511 +20,465	+18%	+$2.22M	0.28%	79
2013 Q2	$11.2M	Buy	+113,046	New	+$11.7M	0.22%	120

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Natixis Advisors's AMGN Position: Q1 2026 in Review

Natixis Advisors increased its Amgen (AMGN) stake by 13% in Q1 2026, buying an estimated $16.4M and bringing the position to 392,002 shares worth $138M. The position accounts for 0.19% of the portfolio, ranked #118.

Natixis Advisors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Natixis Advisors held 392,002 shares of Amgen worth $138M as of Q1 2026.
Natixis Advisors bought 45,963 Amgen shares in Q1 2026, an estimated $16.4M.
Amgen made up 0.19% of Natixis Advisors's portfolio in Q1 2026, its #118 holding.
Natixis Advisors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.